A carregar...

Angptl4 does not control hyperglucagonemia or α-cell hyperplasia following glucagon receptor inhibition

Genetic disruption or pharmacologic inhibition of glucagon signaling effectively lowers blood glucose but results in compensatory glucagon hypersecretion involving expansion of pancreatic α-cell mass. Ben-Zvi et al. recently reported that angiopoietin-like protein 4 (Angptl4) links glucagon receptor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Proc Natl Acad Sci U S A
Main Authors: Okamoto, Haruka, Cavino, Katie, Na, Erqian, Krumm, Elizabeth, Kim, Steven, Stevis, Panayiotis E., Harp, Joyce, Murphy, Andrew J., Yancopoulos, George D., Gromada, Jesper
Formato: Artigo
Idioma:Inglês
Publicado em: National Academy of Sciences 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5347591/
https://ncbi.nlm.nih.gov/pubmed/28143927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1620989114
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!